Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Shares
10,100
Price
$0.04
Total Value
$454.50
Shares Held After
1,056,800
% of Holdings
1.0%

Oruka Therapeutics, Inc. (ORKA)

Agarwal Arjun — Senior Vice President, Finance
Sep 21, 2026
Sale
Shares
533
Price
$95.75
Total Value
$51.03K
Shares Held After
14,219
% of Holdings
3.6%

CYBIN INC. (CYBN)

Halstead Michael — Chief Executive Officer
Sep 21, 2026
Purchase
Shares
100,000
Price
$13.47
Total Value
$1.35M
Shares Held After
168,568
% of Holdings
59.3%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Sep 21, 2026
Sale
Shares
2,667
Price
$95.31
Total Value
$254.20K
Shares Held After
29,995
% of Holdings
8.2%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Sep 21, 2026
Sale
Shares
601
Price
$94.44
Total Value
$56.76K
Shares Held After
32,662
% of Holdings
1.8%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Sep 21, 2026
Sale
Shares
3,832
Price
$93.32
Total Value
$357.59K
Shares Held After
33,263
% of Holdings
10.3%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Sep 21, 2026
Sale
Shares
2,900
Price
$92.37
Total Value
$267.87K
Shares Held After
37,095
% of Holdings
7.3%

Heartflow, Inc. (HTFL)

Rogers Campbell — Chief Medical Officer
Sep 18, 2026
Sale
Shares
19,682
Price
$50.15
Total Value
$987.05K
Shares Held After
79,956
% of Holdings
19.8%
Sep 18, 2026
Sale
Shares
9,132
Price
$3.24
Total Value
$29.55K
Shares Held After
25,384
% of Holdings
26.5%

Bolt Biotherapeutics, Inc. (BOLT)

Nemec Sarah — Senior VP, Finance and PAO
Sep 18, 2026
Sale
Shares
4,077
Price
$3.24
Total Value
$13.19K
Shares Held After
17,082
% of Holdings
19.3%

Bolt Biotherapeutics, Inc. (BOLT)

Yonehiro Grant — Chief Operating Officer
Sep 18, 2026
Sale
Shares
6,850
Price
$3.24
Total Value
$22.17K
Shares Held After
17,269
% of Holdings
28.4%
Sep 18, 2026
Sale
Shares
160
Price
$498.25
Total Value
$79.72K
Shares Held After
324,443
% of Holdings
0.0%
Sep 18, 2026
Sale
Shares
277
Price
$496.64
Total Value
$137.57K
Shares Held After
324,603
% of Holdings
0.1%
Sep 18, 2026
Sale
Shares
2,330
Price
$495.66
Total Value
$1.15M
Shares Held After
324,880
% of Holdings
0.7%
Sep 18, 2026
Sale
Shares
4,269
Price
$494.70
Total Value
$2.11M
Shares Held After
327,210
% of Holdings
1.3%
Sep 18, 2026
Sale
Shares
2,216
Price
$493.78
Total Value
$1.09M
Shares Held After
331,479
% of Holdings
0.7%
Sep 18, 2026
Sale
Shares
248
Price
$492.91
Total Value
$122.24K
Shares Held After
333,695
% of Holdings
0.1%
Sep 18, 2026
Purchase
Shares
100,000
Price
$8.43
Total Value
$843.46K
Shares Held After
927,000
% of Holdings
10.8%

NovaBridge Biosciences (NBP)

Dennis Phillip Andrew — Chief Medical Officer
Sep 18, 2026
Sale
Shares
8,209
Price
$0.71
Total Value
$5.83K
Shares Held After
173,427
% of Holdings
4.5%

CHEMED CORP (CHE)

MCNAMARA KEVIN J — Director
Sep 18, 2026
Sale
Shares
2,000
Price
$501.40
Total Value
$1.00M
Shares Held After
68,418
% of Holdings
2.8%

Heartflow, Inc. (HTFL)

Verghese Vikram — Chief Financial Officer
Sep 18, 2026
Sale
Shares
16,766
Price
$50.75
Total Value
$850.93K
Shares Held After
155,183
% of Holdings
9.8%

BioNTech SE (BNTX)

Sahin Ugur — Chief Executive Officer
Sep 18, 2026
Sale
Shares
30,000
Price
$96.22
Total Value
$2.89M
Shares Held After
489,209
% of Holdings
5.8%

Harmony Biosciences Holdings, Inc. (HRMY)

Budur Kumar — CHIEF MEDICAL OFFICER
Sep 18, 2026
Sale
Shares
35,852
Price
$43.05
Total Value
$1.54M
Shares Held After
13,115
% of Holdings
73.2%
Sep 18, 2026
Sale
Shares
7,837
Price
$16.71
Total Value
$130.96K
Shares Held After
271,765
% of Holdings
2.8%

CRESCENT BIOPHARMA, INC. (CBIO)

McNeill Jonathan — President and COO
Sep 18, 2026
Sale
Shares
3,839
Price
$16.71
Total Value
$64.15K
Shares Held After
134,588
% of Holdings
2.8%
Sep 18, 2026
Sale
Shares
203
Price
$214.25
Total Value
$43.49K
Shares Held After
400
% of Holdings
33.7%
Sep 17, 2026
Sale
Shares
33,800
Price
$7.46
Total Value
$252.15K
Shares Held After
3,448,812
% of Holdings
1.0%
Sep 17, 2026
Sale
Shares
3,415,011
Price
$6.32
Total Value
$21.58M
Shares Held After
3,482,612
% of Holdings
49.5%
Sep 17, 2026
Sale
Shares
13,679
Price
$57.09
Total Value
$780.94K
Shares Held After
16,637
% of Holdings
45.1%

BillionToOne, Inc. (BLLN)

Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Sep 17, 2026
Sale
Shares
5,840
Price
$110.29
Total Value
$644.11K
Shares Held After
700
% of Holdings
89.3%

BillionToOne, Inc. (BLLN)

Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Sep 17, 2026
Sale
Shares
2,920
Price
$110.31
Total Value
$322.10K
Shares Held After
6,540
% of Holdings
30.9%

BillionToOne, Inc. (BLLN)

Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Sep 17, 2026
Sale
Shares
6,968
Price
$110.30
Total Value
$768.56K
Shares Held After
9,460
% of Holdings
42.4%

BillionToOne, Inc. (BLLN)

Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Sep 17, 2026
Sale
Shares
19,384
Price
$110.36
Total Value
$2.14M
Shares Held After
16,428
% of Holdings
54.1%
Sep 17, 2026
Sale
Shares
1,279
Price
$69.57
Total Value
$88.98K
Shares Held After
495,686
% of Holdings
0.3%
Sep 17, 2026
Sale
Shares
8,721
Price
$69.01
Total Value
$601.87K
Shares Held After
496,965
% of Holdings
1.7%
Sep 17, 2026
Sale
Shares
6,545
Price
$3.32
Total Value
$21.72K
Shares Held After
34,516
% of Holdings
15.9%

Bolt Biotherapeutics, Inc. (BOLT)

Nemec Sarah — Senior VP, Finance and PAO
Sep 17, 2026
Sale
Shares
2,922
Price
$3.32
Total Value
$9.70K
Shares Held After
21,159
% of Holdings
12.1%

Bolt Biotherapeutics, Inc. (BOLT)

Yonehiro Grant — Chief Operating Officer
Sep 17, 2026
Sale
Shares
4,909
Price
$3.32
Total Value
$16.29K
Shares Held After
24,119
% of Holdings
16.9%

Schrodinger, Inc. (SDGR)

Akinsanya Karen — President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Sep 17, 2026
Sale
Shares
21,599
Price
$30.00
Total Value
$647.97K
Shares Held After
69,956
% of Holdings
23.6%

Schrodinger, Inc. (SDGR)

Akinsanya Karen — President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Sep 17, 2026
Sale
Shares
10,000
Price
$28.00
Total Value
$280.00K
Shares Held After
91,555
% of Holdings
9.8%

Enliven Therapeutics, Inc. (ELVN)

Collins Helen Louise — CHIEF MEDICAL OFFICER
Sep 17, 2026
Sale
Shares
240
Price
$51.48
Total Value
$12.36K
Shares Held After
25,000
% of Holdings
1.0%

Enliven Therapeutics, Inc. (ELVN)

Collins Helen Louise — CHIEF MEDICAL OFFICER
Sep 17, 2026
Sale
Shares
1,844
Price
$50.71
Total Value
$93.51K
Shares Held After
25,240
% of Holdings
6.8%

Enliven Therapeutics, Inc. (ELVN)

Collins Helen Louise — CHIEF MEDICAL OFFICER
Sep 17, 2026
Sale
Shares
2,916
Price
$50.03
Total Value
$145.89K
Shares Held After
27,084
% of Holdings
9.7%

Enliven Therapeutics, Inc. (ELVN)

Hohl Benjamin — CHIEF FINANCIAL OFFICER
Sep 17, 2026
Sale
Shares
289
Price
$51.49
Total Value
$14.88K
Shares Held After
38,000
% of Holdings
0.8%

Enliven Therapeutics, Inc. (ELVN)

Hohl Benjamin — CHIEF FINANCIAL OFFICER
Sep 17, 2026
Sale
Shares
2,194
Price
$50.72
Total Value
$111.27K
Shares Held After
38,289
% of Holdings
5.4%

Enliven Therapeutics, Inc. (ELVN)

Hohl Benjamin — CHIEF FINANCIAL OFFICER
Sep 17, 2026
Sale
Shares
3,535
Price
$50.03
Total Value
$176.85K
Shares Held After
40,483
% of Holdings
8.0%
Sep 17, 2026
Sale
Shares
10,880
Price
$620.40
Total Value
$6.75M
Shares Held After
504,273
% of Holdings
2.1%

Pharvaris N.V. (PHVS)

Lu Peng — President
Sep 17, 2026
Sale
Shares
100,000
Price
$35.00
Total Value
$3.50M
Shares Held After
64,953
% of Holdings
60.6%
Shares
200,000
Price
$35.00
Total Value
$7.00M
Shares Held After
115,167
% of Holdings
63.5%
Sep 17, 2026
Sale
Shares
869
Price
$163.39
Total Value
$141.99K
Shares Held After
620,589
% of Holdings
0.1%
Version: v26.9.1